Cargando…
Integration of an Expression Platform in the SELEX Cycle to Select DNA Aptamer Binding to a Disease Biomarker
[Image: see text] Aptamers can be developed for biosensors, diagnostic tools, and therapeutic reagents. These applications usually require a fusion of aptamers and expression platforms. However, the fusion process is usually time-consuming and laborious. In this study, we integrated the deoxyribozym...
Autores principales: | Ao, Yaqi, Duan, Anqi, Chen, Binfen, Yu, Xinmei, Wu, Yaoyao, Zhang, Xiaojun, Li, Sanshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973154/ https://www.ncbi.nlm.nih.gov/pubmed/35382297 http://dx.doi.org/10.1021/acsomega.2c00769 |
Ejemplares similares
-
Selection of allosteric dnazymes that can sense phenylalanine by expression-SELEX
por: Chen, Binfen, et al.
Publicado: (2023) -
Probing the Limits of Aptamer Affinity with a Microfluidic SELEX Platform
por: Ahmad, Kareem M., et al.
Publicado: (2011) -
RAPID-SELEX for RNA Aptamers
por: Szeto, Kylan, et al.
Publicado: (2013) -
Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics
por: Stoltenburg, Regina, et al.
Publicado: (2012) -
SELEX: Critical factors and optimization strategies for successful aptamer selection
por: Kohlberger, Michael, et al.
Publicado: (2021)